Press release
Gene Therapy Market Share 2020, Trends, Size - Industry Report 2027
ReportCrux Market Research has published a new report titled “Gene Therapy Market by Vector Type (Viral Vectors [Lentiviruses, Herpes Simplex Virus, Poxvirus, Adenoviruses, Retroviruses, Adeno-Associated Virus, Vaccinia Virus, and Others], and Non-Viral Vectors [Electroporation, Naked/Plasmid Vectors, Gene Gun, Lipofection, and Others); by Delivery Method (In-Vivo, and Ex-Vivo); by Application (Cardiovascular Diseases, Rare Diseases, Oncological Disorders, Neurological Disorders, Infectious Disease, and Other Diseases); and by Region: Global Industry Trends, Dynamics, Competitive Insights and Forecast Analysis, 2020 – 2027”.How much is the Gene Therapy Market worth?
Gene therapy market was valued at approximately USD 1,420.3 Million in 2019 and is expected to generate revenue of around USD 9,254.5 Million by end of 2027, growing at a CAGR of around 26.4% between 2020 and 2027
Request for sample Report: https://www.reportcrux.com/request-sample-report/Gene-Therapy-Market
What Is Gene Therapy Market?
Gene therapy is the method in which a DNA is implanted into a patient for treatment of a medical disorder. Gene therapy is ideal for cancer treatment by breaking down a certain group of cells. Gene therapy ultimately has the ability to destroy cancer cells, remove genetic defects, and avoid cardiovascular disease.
A basic prerequisite for gene therapy is the accurate recognition of the disease-coding genes. Gene therapy accounts for a large share of the pipeline in the pharmaceutical industry, and this is expected to continue as drugs are becoming commercially available in the R&D process in the coming years. Kymriah and Yescarta’s notable approvals in 2017 have spurred these unprecedented developments in the gene therapy market.
What is the Scope of this report?
Rapid and substantial progress in the field of cellular and molecular biology, guided by technological developments in gene-editing and genomic techniques, has led to growing number of approved gene therapies as well as to the expansion of the pipelines. According to the Alliance for Regenerative Medicine (ARM), more than 700 clinical trials were under way at the end of the second quarter of 2019.
The gene and cell therapy industry is experiencing growing pressure for gene therapy buyouts with the recent drug approvals, resulting in high market premiums. Roche purchased, for example, Spark Therapeutics, a corporation that produces and provides gene therapies, in December 2019. The need for tailored care and rising recognition and acceptance among patients of personalized medicines is likely to further activate the global gene therapy industry further in the future. However, the need for an individual case-by-case approach and high treatment costs are likely hinder the global market for gene therapy within the estimated timeframe.
Which segment accounted for the largest Gene Therapy Market share?
The global market for the gene therapy is segmented into vector type, application, delivery method, and region. Based on vector type, the global market for gene therapy is divided into viral vectors, and non-viral vectors. Viral vectors are further segmented into Lentiviruses, herpes simplex virus, poxvirus, adenoviruses, retroviruses, adeno-associated virus, vaccinia virus, and others. The non-viral vectors are further segmented into electroporation, naked/plasmid vectors, gene gun, lipofection, and others. From this, the viral segment accounted for almost 63% share of the market by vector type owing to its easy modifications high accuracy in delivering the gene to the region of interest.
On the basis of delivery methods, the market is categorized in-vivo, and ex-vivo. The ex-vivo segment is likely to grow at high CAGR in the forecast period. The growth in new gene therapy pipeline innovations was seen in 2018 as opposed to previous years. Thus, the number of drug launches, clinical trials, partnerships, and product innovations is growing, which is expected to provide a lucrative opportunity for the growth of the demand for gene therapy during the forecast period. In recent years, the number of applications for gene therapy has risen, including the treatment of numerous incurable and rare diseases like inherited genetic diseases, and cancer. With an increase in the number of compounds being studied through various clinical trials, the count is controlled by the trials designed to improve cancer therapies.
On the basis of application, the market is categorized into cardiovascular diseases, rare diseases, oncological disorders, neurological disorders, infectious disease, and other diseases. The oncological disorders segment held almost 35% share of the market in 2019 Owing to increased cancer incidence worldwide, and rising regulatory acceptance of gene therapy for cancer. However, the segment of cardiovascular diseases is projected to rise at a lucrative pace during the forecast period, due to an increase in the number of gene therapy clinical trials for treating these diseases.
Read more our Analysis: https://www.reportcrux.com/summary/4121/Gene-Therapy-Market
Which region is predicted to have the largest share in the Gene Therapy Market?
Based on regions, the market is bifurcated into Middle East & Africa, Europe, North America, Latin America, and Asia Pacific. North America held almost 39% share of the overall market owing to high disposable income, increasing cancer incidence, and increased support for gene therapy related R&D activities.
Asia-Pacific, however, is projected to report the highest growth over the forecast period, owing to an increase in the number of people vulnerable to various chronic diseases. Additionally, the acceptance and introduction of gene therapy drugs will have a positive effect on the development of the market in developed countries like Australia, Japan, and New Zealand as major factors in the growth of the gene therapy industry.
Which are the prominent Key Players across the globe?
Some of the major players in gene therapy market are AnGes, Inc. (Japan), Amgen, Inc. (U.S.), Gilead Sciences, Inc. (U.S.), Alnylam Pharmaceuticals, Inc. (U.S.), Jazz Pharmaceuticals, Inc. (Ireland), Orchard Therapeutics Plc. (U.K.), Novartis AG (Switzerland), Spark Therapeutics, Inc. (U.S.), Sibiono GeneTech Co. Ltd. (China), MolMed S.p.A. (Italy), Dynavax Technologies (U.S.), Sarepta Therapeutics, Inc. (U.S.), Human Stem Cells Institute (Russia), and Akcea Therapeutics (U.S.)
The growing interest of both private and public investors in gene therapy is expected to accelerate the market entry of new players. It is anticipated that well-established pharmaceutical companies will enter gene therapy to lead companies to adopt strategies like mergers and acquisitions.
Table of Contents (TOC)
1. Global Gene Therapy Market Introduction
o Definition and Taxonomy
o Research Scope
2. Research Methodology
3. Executive Summary
o Global Market Overview and Key Findings by Major Segments
4. Market Dynamics and Industry Trend Analysis
o Market Dynamics
Drivers
Restraints
Opportunities
Challenges
o SWOT Analysis
o PESTLE Analysis
o Porter’s Five Forces Analysis
o Value Chain Analysis
o Market Growth Attractiveness Analysis by Key Segments and Region
5. COVID-19 Impact Analysis and Recovery Path
o Market Overview and COVID-19 Impact
o COVID-19 Recovery Path Analysis
6. Post COVID-19 Industry Dynamics
o Market Dynamics
Drivers
Restraints
Opportunities
Challenges
1. Competitive Landscape and Market Share Analysis by Manufacturers
o Market Competition Scenario
o Manufacturer Market Share
o Manufacturer Intensity Map
o Opportunity Orbits
o Strategic Market Developments
2. Global Gene Therapy Market Value (USD Million), Share (%), Comparison by Key Segments
By Vector Type
• Viral Vectors
o Retroviruses
o Lentiviruses
o Adenoviruses
o Adeno-Associated Virus
o Herpes Simplex Virus
o Poxvirus
o Vaccinia Virus
o Others
• Non-Viral Vectors
o Naked/Plasmid Vectors
o Gene Gun
o Electroporation
o Lipofection
o Others
By Delivery Method
• In-Vivo
• Ex-Vivo
By Application
• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Disease
• Other Diseases
1. Global Gene Therapy Market Value (USD Million), Share (%), Comparison by Region
o North America
North America Regional Market Size and Trend Analysis
U.S.
Canada
Rest of North America
Europe
Europe Regional Market Size and Trend Analysis
Germany
UK
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Asia Pacific Regional Market Size and Trend Analysis
China
Japan
India
Australia
Southeast Asia
Rest of Asia Pacific
Latin America
Latin America Regional Market Size and Trend Analysis
Brazil
Mexico
Rest of Latin America
Middle East and Africa
Middle East and Africa Regional Market Size and Trend Analysis
Saudi Arabia
South Africa
UAE
Rest of Middle East and Africa
1. Company Profiles of Key Manufacturers
o Company Basic Information
o Company Overview
o Financial Highlights
o Product Portfolio
o Business Strategy
o Recent Market Developments
Read Comprehensive Overview of Report: https://www.reportcrux.com/press-release/Gene-Therapy-Market
Related Reports:
Biopharma Market Worth $546.6 billion by 2027
https://www.reportcrux.com/press-release/Biopharma-Market
Artificial Intelligence Market Worth $313.18 billion by 2027
https://www.reportcrux.com/press-release/Artificial-Intelligence-Market
Contact Us:
ReportCrux Market Research
Kemp House 152 - 160 City Road London EC1V 2NX
phone Number: +91 895 615 7215
website: https://www.reportcrux.com/
Report Crux is a global market intelligence aggregator and publisher of market research reports, business information reports, economic and equity reports. We cater a diverse range of industrial sectors along with niche domains and sub-domains within the industry. We offer exclusive blend of cutting-edge market insights for the critical business needs. We have an experienced/professional team of researchers, analysts and consultants that are engaged in gathering and analyzing business information to offer best in class industry report for competitive business needs.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gene Therapy Market Share 2020, Trends, Size - Industry Report 2027 here
News-ID: 2191532 • Views: …
More Releases from ReportCrux Market Research

Fluorescence In Situ Hybridization (FISH) Imaging Systems Market 2022 Size, Anal …
Global Fluorescence In Situ Hybridization (FISH) Imaging Systems market report professionals study based on market drivers, market restraints and its future Aspects with growth trends, various stakeholders like investors, suppliers, SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization. Fluorescence In Situ Hybridization (FISH) Imaging Systems market report study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market.
Fluorescence in…

Commercial Vehicle Telematics Market Size: Top Countries Segmented by Applicatio …
Global Commercial Vehicle Telematics market report 2022 experts contribute the global and regional market with an in-depth analysis of the overall growth prospects in the market. Commercial Vehicle Telematics report offers detailed data of leading companies encompassing their successful marketing strategies, market contribution, and recent developments in both historic and present contexts about Expected Market Status, Market Opportunity and Market Growth in the next five years.
Commercial Vehicle Telematics Market is…

Heat Not Burn Products Market 2022 Analysis by Current Industry Status & Grow …
Global "Heat Not Burn Products market" 2022 report provides Comprehensive report with top key players/manufacturers, suppliers, distributors, traders, customers, investors and major types as well as applications and forecast period for value chain analysis. The Heat Not Burn Products market report provides potential market opportunities for evaluating the Overall Market, underlining opportunities, and supporting strategic and tactical decision-making. The report further offers a dashboard overview of leading companies encompassing their…

Global Foot and Ankle Device Market 2022 Size, Share, Competition, Scope, Status …
Global "Foot and Ankle Device market" 2022 provides a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this countryside. Along with an in-depth explanation on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most detailed documentation that…
More Releases for Gene
DNA and Gene Cloning Services Market Expands with Growing Focus on Complex Gene …
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled "Global DNA and Gene Cloning Services Market by Type of Service Offered (Custom Cloning, Sub-cloning, Gene Synthesis, and Others), Type of Gene (Complex Gene, Standard Gene, and Others), End-User Industry (Pharmaceutical, Academic and R&D, and Biotechnology Companies, and Others)- Market Outlook and Industry Analysis 2034"
The DNA and Gene Cloning Services Market Size is valued…
Evolving Market Trends In The CRISPR Gene Editing Industry: Innovative Gene Ther …
The CRISPR Gene Editing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected CRISPR Gene Editing Market Size During the Forecast Period?
The CRISPR gene editing market has grown exponentially in recent years. It will grow from $2.26 billion in 2024 to $2.88…
Cell and Gene Therapy Market Global Analysis By Type (Cell Therapy, Gene Therapy …
Gene and cell therapy uses genes and cells for the treatment of genetic diseases. Genetic diseases are caused by mutations, or errors in genes which can be passed down from one generation to another. Gene therapy aims to treat diseases by using genetic material, or DNA, to manipulate a patient's cells by replacing, changing or introducing genome into cells- either internally or externally. Cell therapy aims to treat diseases by…
Competitive and Opportunities Analysis of Gene Therapy Market of Gene Therapy Ma …
Global Gene Therapy Market accounted for US$ 2.05 billion in 2020 and is estimated to be US$ 12.29 billion by 2030 and is anticipated to register a CAGR of 19.8%. Gene therapy means fixing a working gene to an individual who features a damaged gene. The European Commission has approved this method for one particular treatment. The treatment by the merchandise Glybera uses an epidemic to infect muscle cells with…
Genetic Testing Market Size by Growth Opportunities, Top Key Players: GeneDx, In …
Genetic Testing Market Report provides an in-depth analysis of the overall market, The ripple effect of Coronavirus-Covid19 on the market needs to become part of strategy discussions to emerge strong. The report focuses on major key players, production details, their application, countries and also analyzes the global and key regions market potential and advantage, opportunity, and challenge, restraints, and risks.
The Top players Covered in report are GeneDx, Invitae, Pathway Genomics,…
Gene Synthesis Market by Top Manufacturers - Gene script, Gene Art (Thermofische …
The "Gene Synthesis Market" report Added by "Big Market Research", enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.
In the Gene Synthesis Market 2018 research report professionals describe the different facets of the industry with a specific goal…